Why American Healthcare Is So Broken

00:20:49
https://www.youtube.com/watch?v=iWMF4e8RG1I

Resumo

TLDRThe video presents a critical examination of the US healthcare system, focusing on its inefficiency, high costs, and lack of quality outcomes. It was triggered by the assassination of United Health Care's CEO, leading to a broader discussion about universal healthcare. Key contributors to the problem include insurance companies that deny claims, complicated administrative procedures, an insufficient number of doctors due to restrictive practices, and pharmaceutical companies that set exorbitant prices without government negotiation. The conclusion raises ethical concerns about prioritizing profits over patient care, suggesting that even with a public healthcare model, outcomes could improve compared to the current system.

ConclusΓ΅es

  • πŸ’‘ Healthcare costs in the US are nearly $5 trillion a year.
  • πŸ“‰ US ranks last in health outcomes among high-income countries.
  • βœ–οΈ Insurance companies deny a significant portion of claims.
  • ⏳ Prior authorization can delay essential care for patients.
  • πŸ’° Private equity often leads to increased healthcare costs.
  • πŸ” Drug prices are significantly higher in the US than elsewhere.
  • πŸ₯ The number of practicing physicians is artificially low in the US.
  • πŸ’Š Pharmaceutical companies do not negotiate drug prices with the government.
  • βš–οΈ The complexity of the healthcare system hinders effective care.
  • πŸ”„ Consolidation in healthcare providers has not improved outcomes.

Linha do tempo

  • 00:00:00 - 00:05:00

    On December 4th, 2024, Brian Thompson, the CEO of United Health Care, is assassinated, triggering a nationwide discussion on the issues plaguing the American health care system. Despite his position, public empathy is scarce as Americans confront a health care landscape characterized by exorbitant spending and poor outcomes, most notably a lower life expectancy compared to other wealthy nations. The staggering cost of nearly $5 trillion annually i.e., 18% of GDP, yields minimal health benefits for the population, driving a demand for reform.

  • 00:05:00 - 00:10:00

    Dissecting the components of US health care, we find insurance prevailing as a culprit, with 92% of Americans insured, primarily through employer and government programs. However, the complexity of insurance leads to a significant administrative burden, taking up 40% of hospital costs. Insurance firms often deny around 16% of claims, leading to a financial strain on patients who delay or forgo necessary treatments, resulting in myriad bankruptcies tied to health care. This denial culture is exacerbated as insurance companies appeal increasingly rarely, despite a high rate of successful appeal overturns.

  • 00:10:00 - 00:15:00

    The situation further deteriorates with the need for prior authorizations, showing a clear misalignment between insurance policies and patient care. Many patients suffer irreversible consequences due to delayed treatments instigated by insurance hurdles, with non-oncologists involved in peer reviews pertaining to oncology cases. Despite the belief that market consolidation would lead to competitive pricing, insurers end up leveraging their increased market power to impose higher costs rather than savings onto the patients.

  • 00:15:00 - 00:20:49

    Beyond insurance, health care providers also contribute significantly to inflated costs, driven by an insufficient supply of physicians orchestrated by the AMA's restrictive policies. The merger trends among hospitals and physician practices primarily driven by private equity further inflate health costs without improving care quality. In tandem, pharmaceutical companies exploit the lack of price negotiations to inflate drug prices across the board exorbitantly, often driven by unethical incentives, leading to dire consequences for patient care and safety in the US health care system.

Mostrar mais

Mapa mental

VΓ­deo de perguntas e respostas

  • What incident sparked the discussion about US healthcare?

    The assassination of Brian Thompson, CEO of United Health Care, prompted national dialogue on healthcare.

  • How much does the US spend on healthcare?

    The US spends nearly $5 trillion on healthcare each year, representing almost 18% of GDP.

  • What are the outcomes of US healthcare compared to other developed nations?

    The US ranks last among ten high-income countries for health outcomes and access, despite spending more.

  • What role do insurance companies play in the healthcare crisis?

    Insurance companies deny a significant percentage of claims, increasing costs and patient burdens.

  • How does patient care get affected by prior authorization?

    Prior authorization can delay necessary care, leading to severe health consequences for patients.

  • What is the impact of private equity on healthcare?

    Private equity ownership often leads to increased prices and decreased quality of care.

  • Why are drug prices higher in the US?

    The US government does not negotiate drug prices directly with pharmaceutical companies, leading to higher costs.

Ver mais resumos de vΓ­deos

Obtenha acesso instantΓ’neo a resumos gratuitos de vΓ­deos do YouTube com tecnologia de IA!
Legendas
en
Rolagem automΓ‘tica:
  • 00:00:00
    December 4th, 2024.
  • 00:00:02
    Midtown Manhattan.
  • 00:00:04
    Early in the morning, Brian Thompson,
  • 00:00:06
    the CEO of United Health
  • 00:00:08
    Care, is gunned down.
  • 00:00:09
    Inscribed into the bullets.
  • 00:00:11
    Deny, depose and defend.
  • 00:00:14
    A reference to the tactics
  • 00:00:16
    used by health care companies
  • 00:00:17
    to increase profits. To the media’s
  • 00:00:19
    surprise
  • 00:00:20
    Americans show little empathy
  • 00:00:22
    towards the victim,
  • 00:00:23
    and instead, a country wide
  • 00:00:25
    discussion begins
  • 00:00:26
    on the state of universal health care.
  • 00:00:28
    Today, Americans spend more on health
  • 00:00:31
    care than every country on Earth
  • 00:00:33
    and by a wide margin.
  • 00:00:35
    Worse yet,
  • 00:00:36
    Americans spend more
  • 00:00:37
    even though they see a doctor 50% less
  • 00:00:41
    than other wealthy nations
  • 00:00:43
    and the cherry on top?
  • 00:00:44
    The average US life
  • 00:00:46
    expectancy is three years
  • 00:00:47
    lower than comparable countries.
  • 00:00:49
    What went wrong?
  • 00:00:51
    This is US health care,
  • 00:00:53
    an American sickness.
  • 00:00:56
    The US
  • 00:00:57
    spends nearly $5
  • 00:00:58
    trillion on health care every year.
  • 00:01:00
    This represents almost 18% of GDP.
  • 00:01:04
    However, for all of this money,
  • 00:01:06
    the US gets very little.
  • 00:01:08
    And ranks
  • 00:01:08
    last among ten high income countries
  • 00:01:11
    for health outcomes and access.
  • 00:01:13
    Even when looking at it
  • 00:01:14
    from a purely financial point of view.
  • 00:01:17
    Improving the US health care system
  • 00:01:19
    could save Americans
  • 00:01:20
    nearly $2.5 trillion.
  • 00:01:24
    That's enough
  • 00:01:24
    to exceed the mandate of Doge
  • 00:01:26
    in one year.
  • 00:01:28
    To understand
  • 00:01:29
    what's driving these high costs
  • 00:01:30
    and poor outcomes,
  • 00:01:31
    we need to break out
  • 00:01:32
    the different components
  • 00:01:34
    of the US health care system.
  • 00:01:35
    Insurance, health care providers
  • 00:01:38
    and pharma.
  • 00:01:39
    Let's start off
  • 00:01:40
    with health care insurance.
  • 00:01:43
    92% of all Americans
  • 00:01:45
    have some form of health insurance.
  • 00:01:47
    Generally, it's
  • 00:01:48
    broken down into employer
  • 00:01:50
    sponsored programs.
  • 00:01:51
    Government programs,
  • 00:01:52
    and individual plans.
  • 00:01:54
    Unlike most of the developed world,
  • 00:01:56
    when Americans have insurance,
  • 00:01:58
    they can select
  • 00:01:58
    from multiple providers.
  • 00:02:00
    This introduces choice,
  • 00:02:01
    which some argue is nice
  • 00:02:03
    and allows the consumer
  • 00:02:05
    to decide what's best for them.
  • 00:02:07
    However, it also introduces complexity.
  • 00:02:10
    Each insurance payer can have different
  • 00:02:12
    billing codes,
  • 00:02:13
    payment processes,
  • 00:02:15
    prior authorization protocols,
  • 00:02:17
    service levels,
  • 00:02:18
    doctor networks,
  • 00:02:19
    pharmacy networks, PBMs, and more.
  • 00:02:22
    The outcome
  • 00:02:23
    providing care becomes
  • 00:02:25
    a lot less about medicine
  • 00:02:27
    and much more about
  • 00:02:28
    administrative functions.
  • 00:02:30
    According to the AHA, 40% of total expenses
  • 00:02:34
    incurred by hospitals
  • 00:02:35
    are related
  • 00:02:36
    to administrative functions.
  • 00:02:38
    Not medicine. Not care.
  • 00:02:40
    Not surgery.
  • 00:02:41
    No admin.
  • 00:02:43
    In fact, when you compare the U.S.
  • 00:02:45
    with other developed
  • 00:02:45
    nations, 30% of the difference in cost
  • 00:02:49
    is directly due
  • 00:02:50
    to administrative overhead
  • 00:02:52
    introduced by the insurance regime.
  • 00:02:55
    But money isn't everything.
  • 00:02:56
    To truly understand the impact.
  • 00:02:58
    We need to look at patient outcomes.
  • 00:03:01
    U.S.
  • 00:03:01
    health insurance
  • 00:03:02
    companies deny 16% of all claims,
  • 00:03:06
    with companies
  • 00:03:06
    like UnitedHealthCare and Medica
  • 00:03:08
    denying 32 and 27%, respectively.
  • 00:03:12
    This means that a doctor
  • 00:03:13
    seeking to provide care
  • 00:03:14
    is being rejected
  • 00:03:15
    by an insurance company.
  • 00:03:17
    nearly one out of every five times.
  • 00:03:20
    Ultimately,
  • 00:03:21
    this leads to patients
  • 00:03:22
    having to make tough decisions
  • 00:03:24
    of paying out of pocket
  • 00:03:25
    or not pursuing care at all.
  • 00:03:28
    For those paying out of pocket,
  • 00:03:29
    it could mean taking on large
  • 00:03:31
    sums of debt,
  • 00:03:32
    often with costs so high that 67%
  • 00:03:35
    of all US bankruptcies
  • 00:03:37
    are healthcare related,
  • 00:03:39
    or they can join the nearly 40%
  • 00:03:42
    of Americans
  • 00:03:42
    who have or know a family member
  • 00:03:45
    who has delayed medical care
  • 00:03:46
    due to cost,
  • 00:03:48
    often paying the ultimate price.
  • 00:03:50
    Health insurance
  • 00:03:51
    companies argue
  • 00:03:52
    that they do this
  • 00:03:53
    to control costs for patients
  • 00:03:55
    and ensure that hospitals
  • 00:03:56
    aren't being overzealous,
  • 00:03:58
    which is partially true.
  • 00:04:00
    But these insurance companies
  • 00:04:02
    are increasing
  • 00:04:03
    the rate of denials over time
  • 00:04:05
    and employing new technologies
  • 00:04:07
    to quickly reject claims.
  • 00:04:09
    From 2022 to 2023,
  • 00:04:11
    care denials increased 20 and 56%
  • 00:04:15
    for commercial
  • 00:04:16
    and Medicare Advantage
  • 00:04:17
    claims, respectively.
  • 00:04:19
    They do this
  • 00:04:19
    because less than 1% of
  • 00:04:21
    all claims are appealed.
  • 00:04:23
    This isn't because patients
  • 00:04:24
    don't believe they need care,
  • 00:04:26
    but appealing is costly.
  • 00:04:28
    complicated and very time consuming.
  • 00:04:31
    Remember, deny, depose and defend.
  • 00:04:34
    To make matters worse, 75%
  • 00:04:37
    of all Medicare Advantage
  • 00:04:39
    denials were overturned.
  • 00:04:41
    That's 216,000 denials.
  • 00:04:45
    The misalignment of incentives
  • 00:04:47
    is so clear and abundant
  • 00:04:49
    that it is shocking
  • 00:04:51
    that this continues.
  • 00:04:52
    It is absolutely in the insurance
  • 00:04:54
    company's best interest
  • 00:04:56
    to deny as often as legally possible,
  • 00:04:59
    regardless of the claim.
  • 00:05:01
    But let's not forget
  • 00:05:03
    this isn't a rejection
  • 00:05:04
    of auto insurance.
  • 00:05:06
    This is possibly preventing a human
  • 00:05:08
    being in their most vulnerable state
  • 00:05:10
    from receiving care that they need.
  • 00:05:13
    But if we dig deeper,
  • 00:05:14
    it continues to get worse.
  • 00:05:17
    Prior
  • 00:05:17
    authorizations are a form of approval
  • 00:05:19
    that insurance companies must provide
  • 00:05:21
    for certain types of care.
  • 00:05:23
    This means that if a doctor requires
  • 00:05:25
    a certain type of care
  • 00:05:26
    for their patient
  • 00:05:27
    before they can proceed,
  • 00:05:29
    they must get approval
  • 00:05:30
    from the insurance company.
  • 00:05:31
    Again,
  • 00:05:32
    insurance payers claim
  • 00:05:34
    that this is to ensure
  • 00:05:35
    that care being provided
  • 00:05:37
    is actually needed, but often it leads
  • 00:05:40
    to extremely negative consequences.
  • 00:05:42
    For instance,
  • 00:05:43
    30% of radiation oncologists
  • 00:05:46
    have had a patient
  • 00:05:47
    admitted into the emergency room
  • 00:05:49
    or have permanent disability
  • 00:05:52
    due to prior authorizations.
  • 00:05:54
    This means that a patient was prevented
  • 00:05:56
    from getting care in a timely manner
  • 00:05:59
    because of the administrative burden
  • 00:06:01
    of prior authorizations,
  • 00:06:02
    and the outcome was life changing
  • 00:06:05
    to receive authorization.
  • 00:06:07
    These oncologists need to draft
  • 00:06:09
    an explanation
  • 00:06:10
    for the insurance companies
  • 00:06:11
    that is reviewed by a doctor,
  • 00:06:13
    referred to as a peer.
  • 00:06:15
    However, 35%
  • 00:06:17
    of these peers aren't oncologists,
  • 00:06:21
    but this isn't solely an issue
  • 00:06:23
    for oncology.
  • 00:06:24
    Across all specialties, doctors claim
  • 00:06:27
    that peers are only qualified
  • 00:06:29
    15% of the time.
  • 00:06:32
    One of the reasons
  • 00:06:33
    the insurance companies
  • 00:06:34
    are able to behave this way
  • 00:06:36
    is because of market concentration.
  • 00:06:38
    73% of commercial markets, 71%
  • 00:06:41
    of Medicare Advantage
  • 00:06:42
    markets, and 90% of ACA
  • 00:06:45
    markets are considered
  • 00:06:46
    highly concentrated.
  • 00:06:47
    Some would argue this is a good thing,
  • 00:06:50
    because theoretically it would mean
  • 00:06:51
    that these insurance companies
  • 00:06:53
    can negotiate
  • 00:06:53
    better rates with hospitals,
  • 00:06:55
    and a smaller
  • 00:06:56
    number of payers
  • 00:06:57
    would lower administrative burden.
  • 00:06:59
    But in reality, this is just not true.
  • 00:07:02
    Multiple mergers
  • 00:07:04
    have been studied over the years,
  • 00:07:05
    including Aetna and Prudential,
  • 00:07:07
    UnitedHealth and Sierra and more.
  • 00:07:09
    When studied, the results are almost
  • 00:07:11
    always the same.
  • 00:07:13
    Premiums rise
  • 00:07:14
    as the market consolidates.
  • 00:07:16
    Instead of passing on savings
  • 00:07:18
    to customers,
  • 00:07:19
    insurers take advantage
  • 00:07:20
    of their market dominance
  • 00:07:21
    and increase prices and profits.
  • 00:07:24
    And this competitive positioning
  • 00:07:25
    is very hard to usurp.
  • 00:07:28
    The barrier
  • 00:07:28
    to entry of launching
  • 00:07:29
    a new paper
  • 00:07:30
    is very high due
  • 00:07:31
    to regulatory requirements.
  • 00:07:33
    Anti-competitive practices and scale.
  • 00:07:36
    These insurance companies
  • 00:07:37
    have gone a step further
  • 00:07:39
    and have begun to vertically integrate
  • 00:07:41
    in 2010.
  • 00:07:42
    The Affordable Care Act
  • 00:07:43
    effectively capped insurance
  • 00:07:44
    profit margins
  • 00:07:46
    by requiring
  • 00:07:46
    that insurers spend 80 to 85%
  • 00:07:49
    of what they collect
  • 00:07:50
    on medical services.
  • 00:07:52
    While this sounds nice in theory,
  • 00:07:54
    in practice
  • 00:07:54
    it led to insurance
  • 00:07:56
    companies seeking profits elsewhere.
  • 00:07:58
    For example, UnitedHealth directly
  • 00:08:01
    employs 10,000 physicians
  • 00:08:03
    and has commercial ties
  • 00:08:05
    to an additional 80,000, combined
  • 00:08:08
    that is 10% of all American doctors.
  • 00:08:11
    Again, this might sound nice,
  • 00:08:13
    but as you concentrate more power
  • 00:08:15
    into the hands of a few payers,
  • 00:08:17
    the ability to increase prices
  • 00:08:19
    and generate greater profits
  • 00:08:21
    also rises.
  • 00:08:22
    This again
  • 00:08:23
    is at odds
  • 00:08:24
    with the goal of achieving
  • 00:08:25
    better health outcomes.
  • 00:08:27
    The problem
  • 00:08:27
    with the current US health
  • 00:08:28
    care insurance regime is that success
  • 00:08:31
    for insurance
  • 00:08:32
    companies is not success
  • 00:08:33
    for the patients.
  • 00:08:35
    The unnecessary complexity
  • 00:08:36
    of the regime,
  • 00:08:37
    mixed with the consolidated power
  • 00:08:39
    of the major players, has failed
  • 00:08:42
    to lower costs
  • 00:08:43
    or improve patient outcomes.
  • 00:08:45
    Put simply, it is fundamentally broken.
  • 00:08:51
    We've
  • 00:08:51
    talked a lot about US
  • 00:08:52
    health insurance companies,
  • 00:08:54
    but they aren't
  • 00:08:55
    the only reason
  • 00:08:56
    the health care system is broken.
  • 00:08:58
    Health care
  • 00:08:58
    providers are also
  • 00:08:59
    a part of the problem.
  • 00:09:01
    Let's start off with doctors.
  • 00:09:03
    This might be hard
  • 00:09:04
    for some to believe,
  • 00:09:05
    but US doctors are a major contributor
  • 00:09:08
    to the overpriced healthcare system.
  • 00:09:10
    Take a look at this chart.
  • 00:09:12
    It shows the compensation for US
  • 00:09:14
    doctors compared
  • 00:09:15
    to doctors of other countries.
  • 00:09:17
    There are many reasons
  • 00:09:18
    why doctors in the US are paid more,
  • 00:09:20
    but one of the primary drivers
  • 00:09:22
    is the low supply of doctors.
  • 00:09:24
    The US has 2.6 practicing physicians
  • 00:09:27
    per 1000 people,
  • 00:09:29
    compared to the OECD average of 3.7.
  • 00:09:32
    But why are there so few doctors
  • 00:09:34
    in the US? Simple.
  • 00:09:36
    The American Medical Association
  • 00:09:38
    artificially constrained supply.
  • 00:09:41
    20 years ago,
  • 00:09:42
    the AMA
  • 00:09:43
    lobbied to reduce
  • 00:09:44
    the number of medical schools,
  • 00:09:46
    cap federal funding for residencies,
  • 00:09:48
    and cut a quarter
  • 00:09:49
    of all residency positions.
  • 00:09:52
    Because, I quote, they were worried
  • 00:09:54
    of an impending surplus of physicians.
  • 00:09:57
    This disgusting
  • 00:09:59
    move of regulatory capture,
  • 00:10:00
    influenced by greed,
  • 00:10:02
    meant
  • 00:10:02
    the number of medical school
  • 00:10:03
    graduates in 1980 was the same as 2005,
  • 00:10:08
    even though the US population
  • 00:10:10
    increased by 30%.
  • 00:10:13
    Now it isn't all the doctor's fault.
  • 00:10:15
    Hospital groups
  • 00:10:16
    and investors are also a big problem.
  • 00:10:19
    Similar to insurance, consolidation
  • 00:10:21
    in hospitals
  • 00:10:22
    and physician practices is very common.
  • 00:10:25
    One of the key drivers
  • 00:10:26
    for consolidation is the high
  • 00:10:28
    administrative burden
  • 00:10:29
    for physicians to remain independent.
  • 00:10:31
    Managing all the complexity
  • 00:10:33
    of a US
  • 00:10:33
    healthcare system
  • 00:10:34
    can not only be time consuming,
  • 00:10:36
    but costly. By joining larger groups
  • 00:10:39
    physicians are often able
  • 00:10:40
    to avoid dealing
  • 00:10:41
    with administrative headache
  • 00:10:43
    that comes with a smaller practice.
  • 00:10:45
    Over the past 20 years,
  • 00:10:46
    there have been 1000 mergers
  • 00:10:48
    among the country's
  • 00:10:49
    5000 hospitals,
  • 00:10:51
    and this extends beyond hospitals.
  • 00:10:53
    Today, three out of every four doctors
  • 00:10:56
    now works for a corporate group
  • 00:10:57
    or hospital.
  • 00:10:59
    Much of this has been executed
  • 00:11:01
    by private equity firms.
  • 00:11:02
    The one benefit of private equity
  • 00:11:04
    is that it
  • 00:11:04
    generally lowers costs
  • 00:11:05
    within practices,
  • 00:11:07
    which should, in theory,
  • 00:11:08
    lead to lower prices for patients.
  • 00:11:10
    However, given patients
  • 00:11:12
    are captive customers,
  • 00:11:13
    private equity groups
  • 00:11:14
    are fully incentivized
  • 00:11:16
    to increase prices.
  • 00:11:17
    It's the perfect investment.
  • 00:11:20
    Based on a recent study.
  • 00:11:21
    When PE firms control
  • 00:11:22
    more than 30% of a market.
  • 00:11:24
    Prices rise meaningfully.
  • 00:11:26
    Specifically, the study saw price
  • 00:11:28
    rises of 18%, 16%, and 13%
  • 00:11:33
    for Gastro
  • 00:11:34
    OBGYN and dermatological practices,
  • 00:11:36
    respectively.
  • 00:11:37
    One of the most egregious
  • 00:11:39
    examples of price rises
  • 00:11:41
    was US Anesthesia Partners.
  • 00:11:43
    After achieving
  • 00:11:44
    significant market
  • 00:11:45
    concentration in Denver.
  • 00:11:47
    USAP was noted as charging
  • 00:11:49
    reimbursement rates
  • 00:11:50
    30 to 40% higher than competing groups.
  • 00:11:54
    By acquiring a large
  • 00:11:55
    share of anesthesiologists
  • 00:11:57
    in the Denver area,
  • 00:11:59
    payers and patients
  • 00:12:00
    had little to no choice
  • 00:12:02
    but to pay whatever USAP asked.
  • 00:12:05
    All of this
  • 00:12:06
    while USAP lowered their own costs.
  • 00:12:10
    The saddest part?
  • 00:12:11
    Quality of care doesn't increase
  • 00:12:14
    and might actually decrease.
  • 00:12:16
    A University of Chicago study
  • 00:12:18
    found that PE ownership
  • 00:12:20
    of nursing homes led to a 10% rise
  • 00:12:23
    in short term mortality rates.
  • 00:12:25
    Another Harvard study
  • 00:12:27
    found that quality of care
  • 00:12:28
    declined once
  • 00:12:30
    a hospital was acquired by PE firms.
  • 00:12:32
    They noted a 25% increase
  • 00:12:35
    in hospital complications
  • 00:12:36
    and a 38% increase
  • 00:12:38
    in bloodstream infections.
  • 00:12:40
    Although this may seem
  • 00:12:41
    surprising to some,
  • 00:12:42
    it makes perfect sense.
  • 00:12:44
    To maximize profits,
  • 00:12:46
    the best course of action
  • 00:12:47
    is to increase the revenue
  • 00:12:49
    per patient, per doctor.
  • 00:12:51
    This operating leverage
  • 00:12:52
    will definitely increase margins,
  • 00:12:54
    but may compromise the quality of care.
  • 00:12:57
    And since most PE deals are financed
  • 00:12:59
    with large sums of debt,
  • 00:13:01
    investors are under pressure
  • 00:13:02
    to generate additional free cash flow
  • 00:13:04
    to pay down the debt.
  • 00:13:06
    This might mean cutting corners
  • 00:13:08
    to stay afloat,
  • 00:13:09
    but it isn't just private hospitals
  • 00:13:11
    or PE back rooms
  • 00:13:12
    that are part of the problem.
  • 00:13:14
    Even nonprofits
  • 00:13:15
    hospitals are exemplifying
  • 00:13:17
    extreme greed.
  • 00:13:19
    For example, the former CEO of UPMC,
  • 00:13:22
    a nonprofit hospital, made nearly
  • 00:13:24
    $13 million in fiscal year 2022.
  • 00:13:29
    Yes, the head of a nonprofit
  • 00:13:31
    hospital made nearly $13 million.
  • 00:13:35
    When asked about his compensation,
  • 00:13:37
    this is what he had to say.
  • 00:13:38
    Well, that's your judgment of it.
  • 00:13:40
    I think my board determines
  • 00:13:43
    what the appropriate
  • 00:13:44
    compensation is for me
  • 00:13:45
    and for all the other executives.
  • 00:13:47
    The conclusion for health care
  • 00:13:48
    providers, again, is simple
  • 00:13:50
    the pursuit of controlling supply
  • 00:13:53
    has led to the ability
  • 00:13:54
    to drive up price
  • 00:13:55
    without concerns for quality of care.
  • 00:13:58
    This applies to doctors
  • 00:13:59
    who have artificially lowered
  • 00:14:01
    their numbers, and clinic groups
  • 00:14:02
    who continue to consolidate
  • 00:14:04
    doctors and power.
  • 00:14:08
    The last element we
  • 00:14:10
    will explore is pharma.
  • 00:14:11
    The United States represents
  • 00:14:13
    approximately 44% of the world's
  • 00:14:15
    pharmaceutical market.
  • 00:14:17
    That's over
  • 00:14:17
    $600 billion on a per capita basis.
  • 00:14:21
    The US spends more on drugs
  • 00:14:22
    than anyone else, spending nearly 50%
  • 00:14:25
    more than the next highest
  • 00:14:26
    country, Germany.
  • 00:14:28
    But why? Is the US
  • 00:14:29
    just buying different,
  • 00:14:30
    better medicines?
  • 00:14:32
    No.
  • 00:14:32
    In fact,
  • 00:14:33
    they're buying
  • 00:14:34
    the exact same medicines.
  • 00:14:36
    But just paying a lot more.
  • 00:14:39
    When Bloomberg analyzed
  • 00:14:40
    eight of the best
  • 00:14:41
    selling drivers in the US,
  • 00:14:42
    even after applying discounts,
  • 00:14:45
    all but one or more expensive in the US
  • 00:14:47
    than any other major country,
  • 00:14:50
    and generally by a wide margin.
  • 00:14:53
    One of the more extreme
  • 00:14:54
    examples is for the chronic
  • 00:14:56
    myeloid leukemia pill Gleevec,
  • 00:14:58
    which costs $90,000 a year more
  • 00:15:01
    in the US
  • 00:15:02
    than the rest of the world, on average.
  • 00:15:04
    The craziest part about this, though?
  • 00:15:06
    The difference in
  • 00:15:07
    price is not just limited
  • 00:15:08
    to the US and other countries.
  • 00:15:10
    Even within states and counties,
  • 00:15:12
    people pay different prices.
  • 00:15:15
    Take a commonly used generic versions
  • 00:15:17
    of a prostate cancer treatment, Zytiga
  • 00:15:20
    they have more than 2200 prices
  • 00:15:22
    in Medicare plans.
  • 00:15:24
    For example, in Northern Michigan
  • 00:15:26
    you'll pay $815,
  • 00:15:28
    but hop around to Lake Michigan
  • 00:15:31
    and it jumps to nearly $3,400.
  • 00:15:35
    One of the reasons given
  • 00:15:36
    by pharmaceutical companies
  • 00:15:37
    as to the high price of drugs
  • 00:15:39
    is R&D costs.
  • 00:15:40
    R&D is often the largest expense
  • 00:15:42
    for pharma companies,
  • 00:15:44
    generally comprising
  • 00:15:45
    20 to 40% of revenues.
  • 00:15:47
    In addition,
  • 00:15:48
    the vast majority of all drug ideas
  • 00:15:50
    fail,
  • 00:15:51
    making the process
  • 00:15:52
    to identify and commercialize
  • 00:15:53
    a new drug
  • 00:15:54
    extremely time consuming and risky.
  • 00:15:57
    However, pharma
  • 00:15:58
    companies still generate
  • 00:16:00
    substantial margins
  • 00:16:01
    and returns on invested capital
  • 00:16:03
    as outside of R&D.
  • 00:16:05
    These pharma companies
  • 00:16:06
    are extremely capital efficient,
  • 00:16:08
    and clearly pharma companies
  • 00:16:10
    are charging less to other countries.
  • 00:16:12
    The main reason medicine in the US is
  • 00:16:14
    so expensive
  • 00:16:15
    is because,
  • 00:16:16
    unlike the rest of the developed world,
  • 00:16:18
    the US government does
  • 00:16:19
    not negotiate directly
  • 00:16:21
    with pharma companies.
  • 00:16:22
    In fact, they aren't even allowed to,
  • 00:16:24
    as per
  • 00:16:25
    the Medicare Noninterference clause,
  • 00:16:28
    by spreading the negotiating power
  • 00:16:29
    across payers.
  • 00:16:31
    The US is unable to realize the scale
  • 00:16:33
    benefits that it has.
  • 00:16:35
    This negotiating power
  • 00:16:36
    was further eroded
  • 00:16:38
    when the Medicaid drug
  • 00:16:39
    rebate program was put in place.
  • 00:16:41
    In essence, the program
  • 00:16:42
    set a maximum
  • 00:16:43
    price for drugs within Medicaid.
  • 00:16:45
    But in doing so,
  • 00:16:46
    pharma companies
  • 00:16:47
    made up for the lost
  • 00:16:48
    revenue with other payers.
  • 00:16:50
    The problem with pharma
  • 00:16:52
    is not only about prices,
  • 00:16:53
    but it's also about ethics.
  • 00:16:55
    In 2014,
  • 00:16:56
    the open Payments
  • 00:16:57
    Database was launched to disclose
  • 00:16:59
    financial relationships
  • 00:17:01
    between health care providers
  • 00:17:02
    and pharma companies.
  • 00:17:04
    Now, you might ask,
  • 00:17:05
    outside of employment,
  • 00:17:06
    why would pharma companies pay doctors?
  • 00:17:09
    Very simple.
  • 00:17:10
    Pharma companies
  • 00:17:11
    want people to use their medicines,
  • 00:17:13
    and the only thing in their way
  • 00:17:15
    is a doctor prescribing it.
  • 00:17:17
    To this end,
  • 00:17:17
    they offer illegal kickbacks
  • 00:17:19
    and other incentives
  • 00:17:20
    to ensure
  • 00:17:21
    that doctors recommend their drug
  • 00:17:23
    and not someone else's.
  • 00:17:24
    Sadly, this behavior is on the rise.
  • 00:17:27
    Since
  • 00:17:27
    2014, payments have grown from 6.5
  • 00:17:30
    billion to $12.8 billion.
  • 00:17:34
    Not all of this is illegal,
  • 00:17:36
    but in our view,
  • 00:17:37
    almost all of it is a gray area.
  • 00:17:39
    How can you be sure
  • 00:17:40
    that a doctor will be objective
  • 00:17:42
    if they have pharma companies
  • 00:17:44
    supporting their research,
  • 00:17:45
    giving them speaking fees,
  • 00:17:47
    hiring them as consultants?
  • 00:17:48
    And most atrocious
  • 00:17:49
    of all, paying them kickbacks.
  • 00:17:52
    There are dozens of examples
  • 00:17:53
    of bad behavior.
  • 00:17:54
    Novartis in 2010, Pfizer in 2014,
  • 00:17:58
    and then more recently, Purdue Pharma
  • 00:18:00
    with the opioid crisis.
  • 00:18:02
    This is not a financial crime.
  • 00:18:04
    Rather, it is a crime against humanity.
  • 00:18:07
    The pharma system is very, very broken.
  • 00:18:10
    Not only do Americans
  • 00:18:11
    pay exorbitant amounts
  • 00:18:13
    for the same drug,
  • 00:18:14
    but they can't even be sure
  • 00:18:15
    that they are being prescribed
  • 00:18:16
    the right medicines.
  • 00:18:21
    Now, that was a ton of information.
  • 00:18:23
    And frankly,
  • 00:18:24
    we cut out a lot,
  • 00:18:25
    including the impact of PBMs,
  • 00:18:27
    hidden fees, price transparency.
  • 00:18:30
    The problems with Medicare Advantage,
  • 00:18:32
    the destruction of rural hospitals,
  • 00:18:34
    and more.
  • 00:18:35
    Simply put,
  • 00:18:36
    the US health care
  • 00:18:37
    system is a behemoth,
  • 00:18:38
    and it is very complicated.
  • 00:18:41
    But from this complexity rises
  • 00:18:43
    extreme inefficiency
  • 00:18:44
    and the failure
  • 00:18:45
    to achieve the right health outcomes.
  • 00:18:47
    That said,
  • 00:18:48
    if you are wealthy
  • 00:18:49
    and financially stable,
  • 00:18:51
    the US health care system
  • 00:18:52
    is likely the best on Earth.
  • 00:18:55
    The US has the most advanced
  • 00:18:56
    technologies,
  • 00:18:57
    the most advanced facilities,
  • 00:18:59
    arguably the best doctors in the world.
  • 00:19:02
    The catch?
  • 00:19:03
    You must be able
  • 00:19:04
    and willing to pay for it.
  • 00:19:06
    The US health care
  • 00:19:07
    system is a Lamborghini.
  • 00:19:09
    Yes, it is capable, but at what cost?
  • 00:19:12
    Would we accept
  • 00:19:13
    a world
  • 00:19:14
    where the only car you can drive
  • 00:19:16
    was a luxury vehicle?
  • 00:19:18
    No.
  • 00:19:19
    Medicine is an enterprise.
  • 00:19:20
    Sure.
  • 00:19:21
    But it's different.
  • 00:19:22
    It's not about selling
  • 00:19:24
    the tastiest cheeseburger.
  • 00:19:25
    Nor is it about changing your car tire,
  • 00:19:28
    so you can get to work.
  • 00:19:29
    It is life or death.
  • 00:19:31
    It is as human as it gets.
  • 00:19:33
    And even if
  • 00:19:34
    you are opposed to a government run
  • 00:19:36
    health care model,
  • 00:19:37
    you have to admit that those models
  • 00:19:40
    are still better
  • 00:19:41
    than what the US has today.
  • 00:19:43
    Not only is the US
  • 00:19:44
    the most expensive in the world,
  • 00:19:47
    but it also has
  • 00:19:48
    some of the worst outcomes
  • 00:19:50
    in the developed world.
  • 00:19:51
    If you have watched our channel
  • 00:19:52
    for a while,
  • 00:19:53
    you might have ascertained
  • 00:19:55
    that we're not exactly socialist.
  • 00:19:57
    In fact,
  • 00:19:58
    you might argue
  • 00:19:59
    we are quite pro-business.
  • 00:20:02
    But don't let that fool you.
  • 00:20:03
    Above everything else,
  • 00:20:04
    we care about ethics and outcomes.
  • 00:20:07
    And to us, it doesn't matter
  • 00:20:09
    whether the US system is public
  • 00:20:11
    or private.
  • 00:20:12
    The fact of the matter is,
  • 00:20:14
    it is a disaster.
  • 00:20:16
    It is a system that would reject care
  • 00:20:18
    to a sick child
  • 00:20:20
    because of prior authorization.
  • 00:20:22
    It is a system
  • 00:20:23
    that would increase
  • 00:20:24
    emergency medicine fees
  • 00:20:25
    and surprise recovering patients
  • 00:20:27
    with an insurmountable bill.
  • 00:20:29
    It is a system where costs continue
  • 00:20:32
    to rise, outcomes continue to decline,
  • 00:20:35
    and nothing seems to improve.
  • 00:20:37
    So we must ask ourselves, is
  • 00:20:39
    greed always good?
  • 00:20:42
    Thank you for watching.
  • 00:20:44
    Subscribe to 2&20
  • 00:20:45
    for more on business, economics
  • 00:20:48
    and politics.
Etiquetas
  • US healthcare
  • health insurance
  • pharmaceuticals
  • administrative costs
  • health outcomes
  • prior authorization
  • private equity
  • medical expenses
  • universal healthcare
  • healthcare reform